Skip to content

Clinical trials

Phase 3 Uveitis trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uveitis Phase: Phase 3 Country / region: Germany Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20091
20104
20111
20122
20141
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Completed6
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Lux Biosciences, Inc.3
XOMA (US) LLC2
Eli Lilly and Company1
Heidelberg University1
Institut de Recherches Internationales Servier1
Priovant Therapeutics, Inc.1
Santen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uveitis15
Uveitis, Intermediate11
Uveitis, Posterior10
Panuveitis9
Behcet Syndrome1
Cardiovascular Diseases1
Dermatitis1
Inflammation1
Macular Edema1
Multiple Sclerosis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.